Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Aubry

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Clinical Epidemiology|July 22, 2017
Existing reporting guidelines for clinical trials are not completely relevant for implantable medical devices: a systematic reviewAnne-France Motte, Stéphanie Diallo, Hélène van den Brink, et al.
European Journal of Neurology|May 3, 2021
Patent foramen ovale closure in stroke patients with migraine in the CLOSE trial. The CLOSE-MIG studyJean-Louis Mas, Benoît Guillon, Anaïs Charles-Nelson, et al.
Clinical Cardiology|February 17, 2016
Clinical Outcome of First- vs Second-Generation DES According to DAPT Duration: Results of ARCTIC-GenerationJean-Philippe Collet, Johanne Silvain, Mathieu Kerneis, et al.
Lancet (London, England)|July 20, 2014
Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trialJean-Philippe Collet, Johanne Silvain, Olivier Barthélémy, et al.
The New England Journal of Medicine|November 6, 2012
Bedside monitoring to adjust antiplatelet therapy for coronary stentingJean-Philippe Collet, Thomas Cuisset, Grégoire Rangé, et al.
International Journal of Cardiology. Heart & Vasculature|June 14, 2021
Young athletes: Preventing sudden death by adopting a modern screening approach? A critical review and the opening of a debatePaolo Angelini, Raja Muthupillai, Alberto Lopez, et al.
European Heart Journal|May 18, 2022
Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trialJean Philippe Collet, Eric Van Belle, Holger Thiele, et al.
Circulation|April 11, 2014
High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: A landmark analysis of the ARCTIC studyGilles Montalescot, Grégoire Rangé, Johanne Silvain, et al.
Archives of Cardiovascular Diseases|March 30, 2016
Optimizing the management of acute coronary syndromes in sub-Saharan Africa: A statement from the AFRICARDIO 2015 Consensus TeamMaurice Kakou-Guikahue, Roland N'Guetta, Jean-Baptiste Anzouan-Kacou, et al.
Lancet (London, England)|September 2, 2016
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trialGuillaume Cayla, Thomas Cuisset, Johanne Silvain, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Clinical Epidemiology|July 22, 2017
Existing reporting guidelines for clinical trials are not completely relevant for implantable medical devices: a systematic reviewAnne-France Motte, Stéphanie Diallo, Hélène van den Brink, et al.
European Journal of Neurology|May 3, 2021
Patent foramen ovale closure in stroke patients with migraine in the CLOSE trial. The CLOSE-MIG studyJean-Louis Mas, Benoît Guillon, Anaïs Charles-Nelson, et al.
Clinical Cardiology|February 17, 2016
Clinical Outcome of First- vs Second-Generation DES According to DAPT Duration: Results of ARCTIC-GenerationJean-Philippe Collet, Johanne Silvain, Mathieu Kerneis, et al.
Lancet (London, England)|July 20, 2014
Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trialJean-Philippe Collet, Johanne Silvain, Olivier Barthélémy, et al.
The New England Journal of Medicine|November 6, 2012
Bedside monitoring to adjust antiplatelet therapy for coronary stentingJean-Philippe Collet, Thomas Cuisset, Grégoire Rangé, et al.
International Journal of Cardiology. Heart & Vasculature|June 14, 2021
Young athletes: Preventing sudden death by adopting a modern screening approach? A critical review and the opening of a debatePaolo Angelini, Raja Muthupillai, Alberto Lopez, et al.
European Heart Journal|May 18, 2022
Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trialJean Philippe Collet, Eric Van Belle, Holger Thiele, et al.
Circulation|April 11, 2014
High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: A landmark analysis of the ARCTIC studyGilles Montalescot, Grégoire Rangé, Johanne Silvain, et al.
Archives of Cardiovascular Diseases|March 30, 2016
Optimizing the management of acute coronary syndromes in sub-Saharan Africa: A statement from the AFRICARDIO 2015 Consensus TeamMaurice Kakou-Guikahue, Roland N'Guetta, Jean-Baptiste Anzouan-Kacou, et al.
Lancet (London, England)|September 2, 2016
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trialGuillaume Cayla, Thomas Cuisset, Johanne Silvain, et al.
Pageof 7